Rezolute (RZLT) Cash from Investing Activities (2012 - 2026)

Rezolute's (RZLT) quarterly Cash from Investing Activities came in at $12.3 million in Q1 2026, down 46.73% year-on-year from $23.1 million in Q1 2025, and down 46.17% quarter-over-quarter from $22.8 million in Q4 2025.

Rezolute (RZLT) Cash from Investing Activities (2012 - 2026) Analysis & Trends

Rezolute has disclosed Cash from Investing Activities across 13 years of filings, most recently posting $12.3 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $12.3 million, down 46.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$33.0 million (down 792.0% YoY), and the FY2025 annual result was -$14.5 million, down 129.86% from the prior year.
  • Cash from Investing Activities came in at $12.3 million for Q1 2026 at Rezolute, down from $22.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $23.1 million in Q1 2025 to a low of -$95.0 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is $2.6 million (2023), against an average of -$6.7 million.
  • Across the five-year window, Cash from Investing Activities jumped 21497.59% in 2023 and sank 1996.01% in 2024, its largest moves.
  • Rezolute's Cash from Investing Activities stood at -$83000.0 in 2022, then surged by 21497.59% to $17.8 million in 2023, then sank by 35.42% to $11.5 million in 2024, then jumped by 98.92% to $22.8 million in 2025, then sank by 46.17% to $12.3 million in 2026.
  • The last three Cash from Investing Activities figures came in at $12.3 million (Q1 2026), $22.8 million (Q4 2025), and -$68.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.89 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn -431.90 Mn
9 Abivax 90.15 Bn 90.15 Bn - 579,519.10
10 Rezolute 415.38 Mn 415.38 Mn - 12.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.28 Mn
Mar 31, 2026 12.28 Mn
Dec 31, 2025 22.81 Mn
Dec 31, 2025 22.81 Mn
Sep 30, 2025 -68.49 Mn
Sep 30, 2025 -68.49 Mn
Jun 30, 2025 346,000.00
Jun 30, 2025 346,000.00
Mar 31, 2025 23.05 Mn
Mar 31, 2025 23.05 Mn
Dec 31, 2024 11.47 Mn
Dec 31, 2024 11.47 Mn
Sep 30, 2024 -49.41 Mn
Sep 30, 2024 -49.41 Mn
Jun 30, 2024 19.66 Mn
Jun 30, 2024 19.66 Mn
Mar 31, 2024 8.67 Mn
Mar 31, 2024 8.67 Mn
Dec 31, 2023 17.76 Mn
Dec 31, 2023 17.76 Mn